”The American Pain Society and its global arm, the International Association for the Study of Pain (IASP), promote opioid use, especially for chronic, noncancer pain and it is an organization with longstanding ties to Purdue that were the subject of a Senate investigation in 2017,” the House members’ report said. “The investigation revealed that multiple organizations that claimed to be independent patient advocacy groups, including the American Pain Society, received significant payments from opioid manufacturers.” The report also charged that the APS was “affiliated with multiple prominent individuals with connections to the opioid industry.”
A past APS president, Dennis Turk, received “personal fees from opioid manufacturers,” the report said. Another past president and former APS board chairman, James Campbell, is “credited with first saying pain should be treated as ‘the fifth vital sign,’ which became a key component of opioid manufacturer-funded promotional materials encouraging higher prescribing rates.”
Another Congressional report, issued by the U.S. Senate Committee on Homeland Security & Governmental Affairs, “Fueling an Epidemic,” said that from 2012 through 2017, the American Pain Society received $962,724, with more than half of that from Purdue. It was one of 14 specialty groups that received nearly $9 million from five opioid manufacturers, including Janssen, Depomed, Insys, and Mylan.